Foundation Medicine is a trusted comprehensive genomic profiling partner, offering a range of products and services that provide valuable insights for doctors, biopharma partners, and patients. With extensive experience in the industry, Foundation Medicine has developed a robust genomic database and conducted significant research to strengthen their offerings. Their portfolio of tests and services offers in-depth genomic insights, supported by a broad range of offerings tailored to each practice they work with.

They specialize in providing actionable insights into the genomics of both rare and common cancers, supporting discovery through commercialization. Moreover, Foundation Medicine has achieved significant milestones, including delivering over 1 million reports and publishing 500+ peer-reviewed publications. Their dedication to innovation is demonstrated by recent updates such as updating their reports to highlight critical findings upfront.

Foundation Medicine's FDA-approved tests, such as FoundationOne CDx and FoundationOne Liquid CDx, serve as valuable companion diagnostics for identifying patients who may benefit from specific therapies. Through their comprehensive and innovative approach, Foundation Medicine aims to enhance cancer treatment planning and improve patient outcomes